CJC-1295 (without DAC): Dosage, Benefits & Research Guide
Also known as: CJC-1295 no DAC, Modified GRF 1-29, Mod-GRF 1-29
What is CJC-1295 (without DAC)?
CJC-1295 without DAC (also known as Modified GRF 1-29 or Mod GRF) is a synthetic 29-amino acid peptide analogue of growth hormone-releasing hormone (GHRH) with four amino acid substitutions (positions 2, 8, 15, and 27) that confer resistance to DPP-IV enzymatic degradation. Its mechanism of action involves binding to GHRH receptors (GHRH-R) on anterior pituitary somatotroph cells, stimulating cAMP-mediated signaling that triggers growth hormone synthesis and secretion. The amino acid modifications extend the peptide's biological half-life from under 10 minutes (native GHRH) to approximately 30 minutes, enabling meaningful GH pulse amplification while still preserving physiological pulsatile release patterns. Research on this modified GHRH analogue demonstrates it produces GH elevations within 15-30 minutes of administration, with return to baseline within 2-3 hours, mimicking natural GH pulse kinetics. Studies suggest CJC-1295 without DAC may support skin thickness and collagen production through GH-mediated IGF-1 elevation (Ionescu and Bhatt, Growth Hormone and IGF Research). Compared to the DAC-conjugated version (CJC-1295 with DAC), the non-DAC form produces shorter, more discrete GH pulses rather than sustained 7-10 day GH elevation, which some research protocols prefer for mimicking physiological patterns. It is frequently paired with ghrelin mimetics like ipamorelin for synergistic effect. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 21 days. This peptide is studied by endocrinology research departments, anti-aging medicine laboratories, and body composition research centers investigating GHRH axis modulation.
CJC-1295 (without DAC) Research Applications
In published and preclinical research, CJC-1295 (without DAC) has been studied across the following areas:
- Pituitary GH release stimulation
- Skin thickness and collagen activity
- Muscle hypertrophy studies
- Cardiac tissue repair research
CJC-1295 (without DAC) in Research: Reconstitution & Study Concentrations
CJC-1295 without DAC (Modified GRF 1-29) is a GHRH analog with four amino-acid substitutions that increase stability relative to native GHRH, but without the albumin-binding Drug Affinity Complex of the DAC variant. This gives it a short half-life studied for pulsatile secretion profiles. Reconstitute the lyophilized peptide with bacteriostatic water for research use.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculatorHow CJC-1295 (without DAC) Compares
Researchers frequently evaluate CJC-1295 (without DAC) alongside related compounds:
- CJC-1295 (without DAC) vs CJC-1295 with DAC — long-acting albumin-bound variant
- CJC-1295 (without DAC) vs Ipamorelin — secretagogue often studied in combination